カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の呼吸器治療用処方薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Prescription Respiratory Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19567）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19567
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：78
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の呼吸器治療用処方薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

呼吸器治療用処方薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の呼吸器治療用処方薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

呼吸器治療用処方薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・抗炎症薬、マストスタビライザー、抗ヒスタミン薬、気管支拡張薬、その他の呼吸薬

用途別セグメントは次のように区分されます。
・病院薬局、ドラッグストア、小売店、EC

世界の呼吸器治療用処方薬市場の主要な市場プレーヤーは以下のとおりです。
・AstraZeneca、Boehringer Ingelheim、GlaxoSmithKline、Merck

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、呼吸器治療用処方薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な呼吸器治療用処方薬メーカーの企業概要、2019年～2022年までの呼吸器治療用処方薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な呼吸器治療用処方薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別呼吸器治療用処方薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの呼吸器治療用処方薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での呼吸器治療用処方薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および呼吸器治療用処方薬の産業チェーンを掲載しています。
・第13、14、15章では、呼吸器治療用処方薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 呼吸器治療用処方薬の概要
- 種類別分析（2017年vs2021年vs2028年）：抗炎症薬、マストスタビライザー、抗ヒスタミン薬、気管支拡張薬、その他の呼吸薬
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、ドラッグストア、小売店、EC
- 世界の呼吸器治療用処方薬市場規模・予測
- 世界の呼吸器治療用処方薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- AstraZeneca、Boehringer Ingelheim、GlaxoSmithKline、Merck
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：抗炎症薬、マストスタビライザー、抗ヒスタミン薬、気管支拡張薬、その他の呼吸薬
・用途別分析2017年-2028年：病院薬局、ドラッグストア、小売店、EC
・呼吸器治療用処方薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・呼吸器治療用処方薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・呼吸器治療用処方薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・呼吸器治療用処方薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・呼吸器治療用処方薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Prescription Respiratory Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prescription Respiratory Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Prescription Respiratory Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-Inflammatories segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Prescription Respiratory Drugs include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prescription Respiratory Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-Inflammatories
Mast Stabilizers
Antihistamines
Bronchodilators
Other Respiratory Drugs
Market segment by Application can be divided into
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
The key market players for global Prescription Respiratory Drugs market are listed below:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prescription Respiratory Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prescription Respiratory Drugs, with price, sales, revenue and global market share of Prescription Respiratory Drugs from 2019 to 2022.
Chapter 3, the Prescription Respiratory Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prescription Respiratory Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Prescription Respiratory Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Respiratory Drugs.
Chapter 13, 14, and 15, to describe Prescription Respiratory Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Prescription Respiratory Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prescription Respiratory Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Anti-Inflammatories
1.2.3 Mast Stabilizers
1.2.4 Antihistamines
1.2.5 Bronchodilators
1.2.6 Other Respiratory Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Prescription Respiratory Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Global Prescription Respiratory Drugs Market Size & Forecast
1.4.1 Global Prescription Respiratory Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Prescription Respiratory Drugs Sales in Volume (2017-2028)
1.4.3 Global Prescription Respiratory Drugs Price (2017-2028)
1.5 Global Prescription Respiratory Drugs Production Capacity Analysis
1.5.1 Global Prescription Respiratory Drugs Total Production Capacity (2017-2028)
1.5.2 Global Prescription Respiratory Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prescription Respiratory Drugs Market Drivers
1.6.2 Prescription Respiratory Drugs Market Restraints
1.6.3 Prescription Respiratory Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Prescription Respiratory Drugs Product and Services
2.1.4 AstraZeneca Prescription Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Prescription Respiratory Drugs Product and Services
2.2.4 Boehringer Ingelheim Prescription Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Prescription Respiratory Drugs Product and Services
2.3.4 GlaxoSmithKline Prescription Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Prescription Respiratory Drugs Product and Services
2.4.4 Merck Prescription Respiratory Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Prescription Respiratory Drugs Breakdown Data by Manufacturer
3.1 Global Prescription Respiratory Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Prescription Respiratory Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Prescription Respiratory Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Prescription Respiratory Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Prescription Respiratory Drugs Manufacturer Market Share in 2021
3.5 Global Prescription Respiratory Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Prescription Respiratory Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prescription Respiratory Drugs Market Size by Region
4.1.1 Global Prescription Respiratory Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Prescription Respiratory Drugs Revenue by Region (2017-2028)
4.2 North America Prescription Respiratory Drugs Revenue (2017-2028)
4.3 Europe Prescription Respiratory Drugs Revenue (2017-2028)
4.4 Asia-Pacific Prescription Respiratory Drugs Revenue (2017-2028)
4.5 South America Prescription Respiratory Drugs Revenue (2017-2028)
4.6 Middle East and Africa Prescription Respiratory Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Prescription Respiratory Drugs Sales in Volume by Type (2017-2028)
5.2 Global Prescription Respiratory Drugs Revenue by Type (2017-2028)
5.3 Global Prescription Respiratory Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Prescription Respiratory Drugs Sales in Volume by Application (2017-2028)
6.2 Global Prescription Respiratory Drugs Revenue by Application (2017-2028)
6.3 Global Prescription Respiratory Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Prescription Respiratory Drugs Sales by Type (2017-2028)
7.2 North America Prescription Respiratory Drugs Sales by Application (2017-2028)
7.3 North America Prescription Respiratory Drugs Market Size by Country
7.3.1 North America Prescription Respiratory Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Prescription Respiratory Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Prescription Respiratory Drugs Sales by Type (2017-2028)
8.2 Europe Prescription Respiratory Drugs Sales by Application (2017-2028)
8.3 Europe Prescription Respiratory Drugs Market Size by Country
8.3.1 Europe Prescription Respiratory Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Prescription Respiratory Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Prescription Respiratory Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Prescription Respiratory Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Prescription Respiratory Drugs Market Size by Region
9.3.1 Asia-Pacific Prescription Respiratory Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Prescription Respiratory Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Prescription Respiratory Drugs Sales by Type (2017-2028)
10.2 South America Prescription Respiratory Drugs Sales by Application (2017-2028)
10.3 South America Prescription Respiratory Drugs Market Size by Country
10.3.1 South America Prescription Respiratory Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Prescription Respiratory Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prescription Respiratory Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Prescription Respiratory Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Prescription Respiratory Drugs Market Size by Country
11.3.1 Middle East & Africa Prescription Respiratory Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Prescription Respiratory Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Prescription Respiratory Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Prescription Respiratory Drugs
12.3 Prescription Respiratory Drugs Production Process
12.4 Prescription Respiratory Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Prescription Respiratory Drugs Typical Distributors
13.3 Prescription Respiratory Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Prescription Respiratory Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Prescription Respiratory Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Prescription Respiratory Drugs Product and Services
Table 6. AstraZeneca Prescription Respiratory Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim Prescription Respiratory Drugs Product and Services
Table 10. Boehringer Ingelheim Prescription Respiratory Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Prescription Respiratory Drugs Product and Services
Table 14. GlaxoSmithKline Prescription Respiratory Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Prescription Respiratory Drugs Product and Services
Table 18. Merck Prescription Respiratory Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global Prescription Respiratory Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global Prescription Respiratory Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in Prescription Respiratory Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global Prescription Respiratory Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Prescription Respiratory Drugs Production Site of Key Manufacturer
Table 24. Prescription Respiratory Drugs New Entrant and Capacity Expansion Plans
Table 25. Prescription Respiratory Drugs Mergers & Acquisitions in the Past Five Years
Table 26. Global Prescription Respiratory Drugs Sales by Region (2017-2022) & (K Units)
Table 27. Global Prescription Respiratory Drugs Sales by Region (2023-2028) & (K Units)
Table 28. Global Prescription Respiratory Drugs Revenue by Region (2017-2022) & (USD Million)
Table 29. Global Prescription Respiratory Drugs Revenue by Region (2023-2028) & (USD Million)
Table 30. Global Prescription Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 31. Global Prescription Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 32. Global Prescription Respiratory Drugs Revenue by Type (2017-2022) & (USD Million)
Table 33. Global Prescription Respiratory Drugs Revenue by Type (2023-2028) & (USD Million)
Table 34. Global Prescription Respiratory Drugs Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Prescription Respiratory Drugs Price by Type (2023-2028) & (USD/Unit)
Table 36. Global Prescription Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 37. Global Prescription Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Global Prescription Respiratory Drugs Revenue by Application (2017-2022) & (USD Million)
Table 39. Global Prescription Respiratory Drugs Revenue by Application (2023-2028) & (USD Million)
Table 40. Global Prescription Respiratory Drugs Price by Application (2017-2022) & (USD/Unit)
Table 41. Global Prescription Respiratory Drugs Price by Application (2023-2028) & (USD/Unit)
Table 42. North America Prescription Respiratory Drugs Sales by Country (2017-2022) & (K Units)
Table 43. North America Prescription Respiratory Drugs Sales by Country (2023-2028) & (K Units)
Table 44. North America Prescription Respiratory Drugs Revenue by Country (2017-2022) & (USD Million)
Table 45. North America Prescription Respiratory Drugs Revenue by Country (2023-2028) & (USD Million)
Table 46. North America Prescription Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 47. North America Prescription Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 48. North America Prescription Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 49. North America Prescription Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 50. Europe Prescription Respiratory Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Prescription Respiratory Drugs Sales by Country (2023-2028) & (K Units)
Table 52. Europe Prescription Respiratory Drugs Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe Prescription Respiratory Drugs Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe Prescription Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Prescription Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Europe Prescription Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Prescription Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific Prescription Respiratory Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific Prescription Respiratory Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific Prescription Respiratory Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific Prescription Respiratory Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific Prescription Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific Prescription Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific Prescription Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific Prescription Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 66. South America Prescription Respiratory Drugs Sales by Country (2017-2022) & (K Units)
Table 67. South America Prescription Respiratory Drugs Sales by Country (2023-2028) & (K Units)
Table 68. South America Prescription Respiratory Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. South America Prescription Respiratory Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. South America Prescription Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 71. South America Prescription Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 72. South America Prescription Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 73. South America Prescription Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa Prescription Respiratory Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa Prescription Respiratory Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa Prescription Respiratory Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa Prescription Respiratory Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa Prescription Respiratory Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa Prescription Respiratory Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa Prescription Respiratory Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa Prescription Respiratory Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Prescription Respiratory Drugs Raw Material
Table 83. Key Manufacturers of Prescription Respiratory Drugs Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Prescription Respiratory Drugs Typical Distributors
Table 87. Prescription Respiratory Drugs Typical Customers
List of Figures
Figure 1. Prescription Respiratory Drugs Picture
Figure 2. Global Prescription Respiratory Drugs Revenue Market Share by Type in 2021
Figure 3. Anti-Inflammatories
Figure 4. Mast Stabilizers
Figure 5. Antihistamines
Figure 6. Bronchodilators
Figure 7. Other Respiratory Drugs
Figure 8. Global Prescription Respiratory Drugs Revenue Market Share by Application in 2021
Figure 9. Hospital Pharmacies
Figure 10. Drug Stores
Figure 11. Retail Stores
Figure 12. E-Commerce
Figure 13. Global Prescription Respiratory Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Prescription Respiratory Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Prescription Respiratory Drugs Sales (2017-2028) & (K Units)
Figure 16. Global Prescription Respiratory Drugs Price (2017-2028) & (USD/Unit)
Figure 17. Global Prescription Respiratory Drugs Production Capacity (2017-2028) & (K Units)
Figure 18. Global Prescription Respiratory Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Prescription Respiratory Drugs Market Drivers
Figure 20. Prescription Respiratory Drugs Market Restraints
Figure 21. Prescription Respiratory Drugs Market Trends
Figure 22. Global Prescription Respiratory Drugs Sales Market Share by Manufacturer in 2021
Figure 23. Global Prescription Respiratory Drugs Revenue Market Share by Manufacturer in 2021
Figure 24. Prescription Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Prescription Respiratory Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Prescription Respiratory Drugs Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Prescription Respiratory Drugs Sales Market Share by Region (2017-2028)
Figure 28. Global Prescription Respiratory Drugs Revenue Market Share by Region (2017-2028)
Figure 29. North America Prescription Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Europe Prescription Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Prescription Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 32. South America Prescription Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Prescription Respiratory Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Global Prescription Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Prescription Respiratory Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Prescription Respiratory Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Prescription Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Prescription Respiratory Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Global Prescription Respiratory Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Prescription Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Prescription Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Prescription Respiratory Drugs Sales Market Share by Country (2017-2028)
Figure 43. North America Prescription Respiratory Drugs Revenue Market Share by Country (2017-2028)
Figure 44. United States Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Prescription Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Prescription Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Prescription Respiratory Drugs Sales Market Share by Country (2017-2028)
Figure 50. Europe Prescription Respiratory Drugs Revenue Market Share by Country (2017-2028)
Figure 51. Germany Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Prescription Respiratory Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Prescription Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Prescription Respiratory Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Prescription Respiratory Drugs Revenue Market Share by Region (2017-2028)
Figure 60. China Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Prescription Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 67. South America Prescription Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 68. South America Prescription Respiratory Drugs Sales Market Share by Country (2017-2028)
Figure 69. South America Prescription Respiratory Drugs Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Prescription Respiratory Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Prescription Respiratory Drugs Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Prescription Respiratory Drugs Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Prescription Respiratory Drugs Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Prescription Respiratory Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Prescription Respiratory Drugs in 2021
Figure 81. Manufacturing Process Analysis of Prescription Respiratory Drugs
Figure 82. Prescription Respiratory Drugs Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の整形外科治療用処方薬市場2022年：市場規模予測（～2028年）
  • 世界の胃腸治療用処方薬市場2022年：市場規模予測（～2028年）
  • 世界の小児科用呼吸器治療薬市場2022年：市場規模予測（～2028年）
  • オンライン処方せん配送サービスの世界市場2023年：処方薬、健康補助食品、OTC医薬品、診断キット
  • 処方片頭痛薬のグローバル市場展望 2023年-2029年：スマトリプタン、リザトリプタン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19567 )"世界の呼吸器治療用処方薬市場2022年：市場規模予測（～2028年）" (英文：Global Prescription Respiratory Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。